BAY 876 structure
|
Common Name | BAY 876 | ||
---|---|---|---|---|
CAS Number | 1799753-84-6 | Molecular Weight | 496.417 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | 632.3±55.0 °C at 760 mmHg | |
Molecular Formula | C24H16F4N6O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 336.2±31.5 °C |
Use of BAY 876BAY-876 is the first highly selective GLUT1 inhibitor with IC50 of 0.002 uM. show good metabolic stability in vitro and high oral bioavailability in vivo. |
Name | N4-[1-(4-Cyanobenzyl)-5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-7-fluoro-2,4-quinolinedicarboxamide |
---|---|
Synonym | More Synonyms |
Description | BAY-876 is the first highly selective GLUT1 inhibitor with IC50 of 0.002 uM. show good metabolic stability in vitro and high oral bioavailability in vivo. |
---|---|
Related Catalog | |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 632.3±55.0 °C at 760 mmHg |
Molecular Formula | C24H16F4N6O2 |
Molecular Weight | 496.417 |
Flash Point | 336.2±31.5 °C |
Exact Mass | 496.127075 |
LogP | 3.89 |
Vapour Pressure | 0.0±1.9 mmHg at 25°C |
Index of Refraction | 1.649 |
Storage condition | -20℃ |
N-[1-(4-Cyanobenzyl)-5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-7-fluoro-2,4-quinolinedicarboxamide |
2,4-Quinolinedicarboxamide, N-[1-[(4-cyanophenyl)methyl]-5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-7-fluoro- |
BAY-876 |